Biocon share price has rallied over 20% in one month and has gained 17% in three months. The stock has surged 28% in six ...
Siddharth Mittal resigned as CEO and MD of Biocon on Friday.
Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!